Skip to main content

Table 4 Adverse events

From: Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma

Adverse events

Grade 1–2

Grade 3–4

Alopecia

88.2% (15/17)

 

Neutropenia

64.7% (11/17)

17.6% (3/17)

Fatigue

52.9% (9/17)

11.8% (2/17)

Anemia

47.1% (8/17)

11.8% (2/17)

Nausea

41.2% (7/17)

5.9% (1/17)

Leukopenia

35.3% (6/17)

11.8% (2/17)

Peripheral neuropathy

29.4% (5/17)

5.9% (1/17)

Anorexia

29.4% (5/17)

 

Diarrhea

23.5% (4/17)

5.9% (1/17)

Thrombocytopenia

23.5% (4/17)

5.9% (1/17)

Alkaline phosphatase increased

17.6% (3/17)

 

Fever

11.8% (2/17)

 

Abdominal pain

11.8% (2/17)

 

Pneumonitis

5.9% (1/17)

 
  1. Data are presented as percentages (number events/total)